These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 29688031)
1. Gynecologic Serous Carcinoma: An Immunohistochemical Analysis of Malignant Body Fluid Specimens. Ren S; Klump W Arch Pathol Lab Med; 2019 Jun; 143(6):677-682. PubMed ID: 29688031 [TBL] [Abstract][Full Text] [Related]
2. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall. Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841 [TBL] [Abstract][Full Text] [Related]
3. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
4. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy. Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107 [TBL] [Abstract][Full Text] [Related]
5. Pax8: a marker for carcinoma of Müllerian origin in serous effusions. Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683 [TBL] [Abstract][Full Text] [Related]
6. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma. McKnight R; Cohen C; Siddiqui MT Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292 [TBL] [Abstract][Full Text] [Related]
7. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers. Weissferdt A; Rodriguez-Canales J; Liu H; Fujimoto J; Wistuba II; Moran CA Hum Pathol; 2015 Mar; 46(3):376-83. PubMed ID: 25576290 [TBL] [Abstract][Full Text] [Related]
8. Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens. Zhao L; Guo M; Sneige N; Gong Y Am J Clin Pathol; 2012 Feb; 137(2):304-9. PubMed ID: 22261458 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions. Wiseman W; Michael CW; Roh MH Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455 [TBL] [Abstract][Full Text] [Related]
10. A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma. Leivo MZ; Elson PJ; Tacha DE; Delahunt B; Hansel DE Pathology; 2016 Oct; 48(6):543-9. PubMed ID: 27594510 [TBL] [Abstract][Full Text] [Related]
11. Morphologic and Immunocytochemical Features of High-Grade Serous Carcinoma of Ovary in Ascitic Fluid Effusion and Fine-Needle Aspiration Cytology. Bansal A; Srinivasan R; Rohilla M; Sundaram A; Rai B; Rajwanshi A; Suri V; Saha SC; Gupta N; Gupta P; Dey P Am J Clin Pathol; 2020 Jun; 154(1):103-114. PubMed ID: 32271370 [TBL] [Abstract][Full Text] [Related]
12. Utility of uroplakin II expression as a marker of urothelial carcinoma. Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628 [TBL] [Abstract][Full Text] [Related]
14. PAX2 and PAX8: useful markers for metastatic effusions. Waters L; Crumley S; Truong L; Mody D; Coffey D Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997 [TBL] [Abstract][Full Text] [Related]
15. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study. El Hag MI; Ha J; Farag R; El Hag AM; Michael CW Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760 [TBL] [Abstract][Full Text] [Related]
16. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Chang A; Brimo F; Montgomery EA; Epstein JI Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors. Fischer AK; Pham DL; Bösmüller H; Lengerke C; Wagner P; Bachmann C; Beschorner C; Perner S; Kommoss S; Fend F; Staebler A Virchows Arch; 2019 Oct; 475(4):479-488. PubMed ID: 31451895 [TBL] [Abstract][Full Text] [Related]
18. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
19. Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma. Hoang LL; Tacha D; Bremer RE; Haas TS; Cheng L Appl Immunohistochem Mol Morphol; 2015; 23(10):711-6. PubMed ID: 25611245 [TBL] [Abstract][Full Text] [Related]
20. Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Ordóñez NG Mod Pathol; 2013 Apr; 26(4):553-62. PubMed ID: 23196794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]